Sign In
Buy ACRS
$4.42
-0.210 (-4.54%)
At Close: Jun 03, 2026
ACTIA : Chiffre d’affaires du 2ème trimestre 2020
12:00am, Wednesday, 05'th Aug 2020
Regulatory News: ACTIA (Paris:ATI) : IFRS, en M€ 2020* 2019 Var. 1er trimestre 117,1 134,4 <12,8%> 2ème trimestre 84,9 129,8 <34,6%> dont
42% of Americans Feel Uncomfortable Paying Out-of-Pocket for Chronic Pain Treatment, ATI Physical Therapy National Survey Finds
04:55pm, Tuesday, 04'th Aug 2020Allegheny Technologies Inc (ATI) Q2 2020 Earnings Call Transcript | The Motley Fool
04:30pm, Tuesday, 04'th Aug 2020
ATI earnings call for the period ending June 30, 2020.
Aclaris Therapeutics Inc (NASDAQ:ACRS) Short Interest Down 9.5% in July
03:46am, Tuesday, 04'th Aug 2020
Aclaris Therapeutics Inc (NASDAQ:ACRS) saw a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 1,240,000 shares, a decrease of 9.5% from
ATI Announces Second Quarter 2020 Results
12:00am, Tuesday, 04'th Aug 2020
ATI Announces Second Quarter 2020 Results
Allegheny Technologies (ATI) Scheduled to Post Earnings on Tuesday
02:08am, Sunday, 02'nd Aug 2020
Allegheny Technologies (NYSE:ATI) is set to release its earnings data before the market opens on Tuesday, August 4th. Analysts expect Allegheny Technologies to post earnings of ($0.11) per share for t
Cashing in super to buy property not the best idea
12:00pm, Tuesday, 28'th Jul 2020
Renting is likely to be the better option when seeking a holiday home than missing out on the income and growth of a substantial share portfolio.
Two Sigma Advisers LP Sells 23,200 Shares of Aclaris Therapeutics Inc (NASDAQ:ACRS)
04:30pm, Thursday, 16'th Jul 2020
Two Sigma Advisers LP lessened its position in shares of Aclaris Therapeutics Inc (NASDAQ:ACRS) by 40.1% in the first quarter, according to the company in its most recent 13F filing with the Securitie
Aclaris (ACRS) Surges: Stock Moves 5.4% Higher
12:43pm, Wednesday, 08'th Jul 2020
Aclaris (ACRS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Aclaris Therapeutics, Inc. (ACRS), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates for immuno-inflammatory diseases, today announced that it has submitted an
Zacks: Brokerages Expect Aclaris Therapeutics Inc (NASDAQ:ACRS) to Announce -$0.34 Earnings Per Share
01:36am, Saturday, 04'th Jul 2020
Equities analysts predict that Aclaris Therapeutics Inc (NASDAQ:ACRS) will post ($0.34) earnings per share for the current quarter, Zacks reports. Three analysts have made estimates for Aclaris Therap
Is Aclaris Therapeutics, Inc. (ACRS) A Good Stock To Buy?
06:30pm, Friday, 26'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Aclaris Therapeutics (NASDAQ:ACRS) versus Aytu Bioscience (NASDAQ:AYTU) Financial Analysis
02:24am, Wednesday, 24'th Jun 2020
Aclaris Therapeutics (NASDAQ:ACRS) and Aytu Bioscience (NASDAQ:AYTU) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strengt
Aclaris Therapeutics (NASDAQ:ACRS) Stock Price Down 4.3%
02:30am, Sunday, 21'st Jun 2020
Aclaris Therapeutics Inc (NASDAQ:ACRS)’s share price dropped 4.3% during trading on Friday . The company traded as low as $1.55 and last traded at $1.57, approximately 8,317 shares changed hands dur
Aclaris Gets FDA Nod to Start Investigator-led Coronavirus Study
02:12pm, Thursday, 18'th Jun 2020
Aclaris (ACRS) announces that it supports an IND application to evaluate its oral investigational MK2 inhibitor compound, ATI-450, in hospitalized patients with COVID-19.
